Abstract: A medical lead is configured to be implanted into a patients body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section electrically coupled to the first section and configured to be capacitively coupled to the patient's body.

Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section electrically coupled to the first section and configured to be capacitively coupled to the patient's body.

Abstract: A neurostimulation lead is configured to be implanted into a patient's body and has at least one distal electrode. The lead comprises at least one conductive filer electrically coupled to the distal electrode, a jacket for housing the conductive filer and a shield surrounding at least a portion of the filer for reducing electromagnetic coupling to the filer.

Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.

Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section capacitively coupled to the first section and configured to be electrically coupled to the patient's body.

Abstract: A neurostimulation lead is configured to be implanted into a patient's body and has at least one distal electrode. The lead comprises at least one conductive filer electrically coupled to the distal electrode, a jacket for housing the conductive filer and a shield surrounding at least a portion of the filer for reducing electromagnetic coupling to the filer.

Abstract: Targeted binding agents, such antibodies directed to the antigen ?V?6 and uses of such agents are described. In particular, fully human monoclonal antibodies directed to the antigen ?V?6 are disclosed. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3 are disclosed. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also disclosed.

Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section capacitively coupled to the first section and configured to be electrically coupled to the patient's body.

Abstract: A stimulation lead to be implanted into a patient's body includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket houses the conductive filer and provides a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.

Abstract: The invention relates to targeted binding agents against KDR and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to KDR. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of KDR and as diagnostics.

Abstract: The invention relates to targeted binding agents against CD105 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to CD105. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of CD105 and as diagnostics.

Abstract: The present invention relates to compounds that inhibit of a5b1 function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm blooded animals such as humans of diseases that have a significant angiogenesis or vascular component such as for treatment of solid tumours. The present invention also relates to compounds that inhibit a5b1, and also that exhibit appropriate selectivity profile(s) against other integrins.

Abstract: The general goal of the present invention is to prevent damage to property resulting from the animal's separation anxiety which typically is a consequence of the pet owner's departure while minimizing the period of time the dog is confined. The most obvious objective is to restrain the animal until it calms down. A similar approach would be to reward the animal with a treat once it has calmed down. We have invented a device that incorporates an automatically releasing door of the kennel. For instance, the owner of a canine would place the dog in a kennel prior to leaving his or her residence. The owner would initiate a timer on the kennel, and the kennel door would automatically open after a pre-determined amount of time, for instance 30 minutes, or some other amount of time that was sufficient to calm the canine's emotions. After the door is automatically open, the canine would be free to exit the kennel for exercise, to access water and/or food, or otherwise explore the dwelling or its surroundings.

Abstract: A pulse stimulation system configured for implantation into a patient's body comprises a pulse stimulator, a conductive stimulation lead having a proximal end electrically coupled to the pulse simulator and having a distal end, and an electrode assembly coupled to the distal end of the stimulation lead. The electrode assembly comprises an electrode body having a therapy electrode thereon that is electrically coupled to the stimulation lead for delivering therapy to the patient. A floating electrode is configured to contact the patient's body tissue and has a surface area substantially larger than that of the therapy electrode. A filter is coupled between the therapy electrode and the floating electrode for diverting RF energy toward the floating electrode and away from the therapy electrode.

Abstract: A toilet training device has a target sensor for sensing an impact of urine, a first suction cup for securing the target sensor to a toilet, a music box for providing a feedback, and an insulated electric wire for connecting the target sensor with the music box. The target sensor can be positioned unobtrusively within the toilet. When a user urinates, the target sensor detects an impact of the urine when hit, and the target sensor triggers music in the music box through the insulated electric wire.

Abstract: A digital camera that recognizes printed or written words, and converts those words into recognizable speech in either native or foreign tongue. The user points the camera at a printed/text object and the camera will speak (or optionally display) the words. Using this device, a blind or visually disabled person can point at an object, press the shutter button to “take a picture” of the words before him/her, and the camera will speak those words in his/her native language. In a second and more advanced configuration, a person can point this camera at a worded object, press the shutter button to “take a picture” of the words before him/her and the camera will speak those words in a foreign language. Alternatively, he/she may point at text in a foreign language and have those words translated and spoken in his/her native language.

Abstract: An improved control apparatus that automatically maintains line balance and prevents part jam up in a manufacturing process by selectively removing parts from a conveyor line coupling successive manufacturing stations. The apparatus includes a stationary proximity sensor and air knife mounted with respect to the conveyor line, a timer, a solenoid-operated air valve for coupling the air knife to a source of compressed air, and an excess part bin adjacent the conveyor line. When the proximity sensor is closed for more than a first predetermined interval, an impending jam-up of parts is detected, and the timer activates the solenoid-operated air valve for a second predetermined interval, causing the air knife to blow one or more parts from the conveyor line into the excess parts bin. A manually operated switch may be provided for continually activating the air valve to remove all parts during maintenance operations.

Abstract: A process for determining one or more leachate concentrations of one or more components of a glass composition in an aqueous solution of the glass composition by identifying the components of the glass composition, including associated oxides, determining a preliminary glass dissolution estimator, .DELTA.G.sub.p, based upon the free energies of hydration for the component reactant species, determining an accelerated glass dissolution function, .DELTA.G.sub.a, based upon the free energy associated with weak acid dissociation, .DELTA.G.sub.a.sup.WA, and accelerated matrix dissolution at high pH, .DELTA.G.sub.a.sup.SB associated with solution strong base formation, and determining a final hydration free energy, .DELTA.G.sub.f. This final hydration free energy is then used to determine leachate concentrations for elements of interest using a regression analysis and the formula log.sub.10 (N C.sub.i (g/L))=a.sub.i +b.sub.i .DELTA.G.sub.f.

Abstract: An inflatable support is made of a vapor permeable material capable of sustaining an inflated state for significant periods without replenishment so as to provide good pressure distribution whilst allowing breathing to prevent sweating.

Abstract: An inflatable support is made of a vapour permeable material capable of sustaining an inflated state for significant periods without replenishment so as to provide good pressure distribution whilst allowing breathing to prevent sweating.